Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?

Goyal S, Chauhan SK, El Annan J, Nallasamy N, Zhang Q, Dana R.

Arch Ophthalmol. 2010 Jul;128(7):819-24. doi: 10.1001/archophthalmol.2010.124.

2.

Mediators of ocular angiogenesis.

Qazi Y, Maddula S, Ambati BK.

J Genet. 2009 Dec;88(4):495-515. Review.

3.

The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.

Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, Fogel M, Huszar M, White MR, Dinarello CA, Apte RN.

J Immunol. 2009 Oct 1;183(7):4705-14. doi: 10.4049/jimmunol.0901511. Epub 2009 Sep 14.

4.

Expression of vascular endothelial growth factors C and D correlates with lymphangiogenesis and lymph node metastasis in lung adenocarcinoma.

Bo C, Xiaopeng D, Chuanliang P, Xiaogang Z.

Thorac Cardiovasc Surg. 2009 Aug;57(5):291-4. doi: 10.1055/s-0029-1185625. Epub 2009 Jul 23.

PMID:
19629892
5.

Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2.

Goyal S, Chauhan SK, Zhang Q, Dana R.

Arch Ophthalmol. 2009 Jul;127(7):882-7. doi: 10.1001/archophthalmol.2009.125.

PMID:
19597109
6.

Role of Th17 cells in the immunopathogenesis of dry eye disease.

Chauhan SK, Dana R.

Mucosal Immunol. 2009 Jul;2(4):375-6. doi: 10.1038/mi.2009.21. No abstract available.

7.

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

Ciulla TA, Rosenfeld PJ.

Curr Opin Ophthalmol. 2009 May;20(3):166-74. doi: 10.1097/ICU.0b013e328329d173. Review.

PMID:
19381089
8.

Characterization of effector T cells in dry eye disease.

El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R.

Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3802-7. doi: 10.1167/iovs.08-2417. Epub 2009 Apr 1.

9.

Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.

Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, Dana R.

J Immunol. 2009 Feb 1;182(3):1247-52.

10.

Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease.

Ecoiffier T, El Annan J, Rashid S, Schaumberg D, Dana R.

Arch Ophthalmol. 2008 Dec;126(12):1695-9. doi: 10.1001/archopht.126.12.1695.

PMID:
19064851
11.

Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.

Watari K, Nakao S, Fotovati A, Basaki Y, Hosoi F, Bereczky B, Higuchi R, Miyamoto T, Kuwano M, Ono M.

Biochem Biophys Res Commun. 2008 Dec 19;377(3):826-31. doi: 10.1016/j.bbrc.2008.10.077. Epub 2008 Oct 23.

PMID:
18951870
12.

Lymphangiogenesis in development and disease.

Mäkinen T, Alitalo K.

Novartis Found Symp. 2007;283:87-98; discussion 98-105, 238-41.

PMID:
18300416
13.

Topical omega-3 and omega-6 fatty acids for treatment of dry eye.

Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR.

Arch Ophthalmol. 2008 Feb;126(2):219-25. doi: 10.1001/archophthalmol.2007.61.

PMID:
18268213
14.
15.
16.
17.

Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.

Tobler NE, Detmar M.

J Leukoc Biol. 2006 Oct;80(4):691-6. Epub 2006 Jun 22. Review.

PMID:
16793912
18.

Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis.

Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J, Siemasko K.

J Immunol. 2006 Apr 1;176(7):3950-7.

19.

The crucial role of macrophages in lymphangiogenesis.

Kerjaschki D.

J Clin Invest. 2005 Sep;115(9):2316-9.

20.

The controlled-environment chamber: a new mouse model of dry eye.

Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR.

Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2766-71.

PMID:
16043849

Supplemental Content

Support Center